Kenvue Inc. reported on September 8, 2026, regarding a study suggesting a potential link between the use of Tylenol (acetaminophen) during pregnancy and specific changes in the reproductive organs of daughters.
The news, sourced from Reuters and reported by Benzinga, highlights findings that indicate Tylenol use may be associated with changes in the uterus and ovaries of female offspring. The report does not specify the exact nature of the changes or the dosage levels involved in the study.
As of the most recent data provided, Kenvue Inc. is trading at $17.91, representing a decrease of 2.64%.
